» Articles » PMID: 38205550

Exercise Microdosing for Skeletal Muscle Health Applications to Spaceflight

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Findings from a recent 70-day bedrest investigation suggested intermittent exercise testing in the control group may have served as a partial countermeasure for skeletal muscle size, function, and fiber-type shifts. The purpose of the current study was to investigate the metabolic and skeletal muscle molecular responses to the testing protocols. Eight males (29 ± 2 yr) completed muscle power (6 × 4 s; peak muscle power: 1,369 ± 86 W) and V̇o (13 ± 1 min; 3.2 ± 0.2 L/min) tests on specially designed supine cycle ergometers during two separate trials. Blood catecholamines and lactate were measured pre-, immediately post-, and 4-h postexercise. Muscle homogenate and muscle fiber-type-specific [myosin heavy chain (MHC) I and MHC IIa] mRNA levels of exercise markers () and , , and were measured from vastus lateralis muscle biopsies obtained pre- and 4-h postexercise. The muscle power test altered ( ≤ 0.05) norepinephrine (+124%), epinephrine (+145%), lactate (+300%), and muscle homogenate mRNA (). The V̇o test altered ( ≤ 0.05) norepinephrine (+1,394%), epinephrine (+1,412%), lactate (+736%), and muscle homogenate mRNA (). In general, both tests influenced MHC IIa muscle fibers more than MHC I with respect to the number of genes that responded and the magnitude of response. Both tests also influenced mRNA expression in a muscle fiber-type-specific manner. These findings provide unique insights into the adaptive response of skeletal muscle to small doses of exercise and could help shape exercise dosing for astronauts and Earth-based individuals. Declines in skeletal muscle health are a concern for astronauts on long-duration spaceflights. The current findings add to the growing body of exercise countermeasures data, suggesting that small doses of specific exercise can be beneficial for certain aspects of skeletal muscle health. This information can be used in conjunction with other components of existing exercise programs for astronauts and might translate to other areas focused on skeletal muscle health (e.g., sports medicine, rehabilitation, aging).

Citing Articles

Endurance exercise attenuates Gαq-RNAi induced hereditary obesity and skeletal muscle dysfunction via improving skeletal muscle Srl/MRCC-I pathway in Drosophila.

Yin X, Wen D, Li H, Gao Z, Gao Y, Hao W Sci Rep. 2024; 14(1):28207.

PMID: 39548180 PMC: 11568267. DOI: 10.1038/s41598-024-79415-x.


NASA SPRINT exercise program efficacy for vastus lateralis and soleus skeletal muscle health during 70 days of simulated microgravity.

Trappe T, Minchev K, Perkins R, Lavin K, Jemiolo B, Ratchford S J Appl Physiol (1985). 2024; 136(5):1015-1039.

PMID: 38328821 PMC: 11365553. DOI: 10.1152/japplphysiol.00489.2023.

References
1.
Lamon S, Wallace M, Stefanetti R, Rahbek S, Vendelbo M, Russell A . Regulation of the STARS signaling pathway in response to endurance and resistance exercise and training. Pflugers Arch. 2013; 465(9):1317-25. DOI: 10.1007/s00424-013-1265-5. View

2.
Murach K, Raue U, Wilkerson B, Minchev K, Jemiolo B, Bagley J . Single muscle fiber gene expression with run taper. PLoS One. 2014; 9(9):e108547. PMC: 4182496. DOI: 10.1371/journal.pone.0108547. View

3.
Milanovic Z, Sporis G, Weston M . Effectiveness of High-Intensity Interval Training (HIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials. Sports Med. 2015; 45(10):1469-81. DOI: 10.1007/s40279-015-0365-0. View

4.
Wallace M, Hock M, Hazen B, Kralli A, Snow R, Russell A . Striated muscle activator of Rho signalling (STARS) is a PGC-1α/oestrogen-related receptor-α target gene and is upregulated in human skeletal muscle after endurance exercise. J Physiol. 2011; 589(Pt 8):2027-39. PMC: 3090601. DOI: 10.1113/jphysiol.2011.205468. View

5.
Ohkawa Y, Marfella C, Imbalzano A . Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1. EMBO J. 2006; 25(3):490-501. PMC: 1383528. DOI: 10.1038/sj.emboj.7600943. View